GMP News - APIs and Excipients

03.08.11

New EMA Draft Guideline on Stability Data regarding Applications for Variations to a Marketing Authorisation

Because of the extensive reorganisation of applications for variations contained in the Variations Regulation from 2010, a revision of the "Guideline on stability testing for applications for variations to a marketing authorisation" became necessary. Read here, which stability testing data are required by regulatory authorities in case of applications for variations.

more

27.07.11

Warning of Potential Contamination with Toxic Plasticizer

The recent discovery about the fraudulent replacement of vegetal oils as emulsifiers with toxic plasticizers in the products of two Taiwanese companies has led both the FDA and the IPEC Europe to publish warning notifications. Read more here about the incident.

more

27.07.11

MPA Proposal: No GMP Certificate in Case of Violation of environmental Constraints

In a 46 page report, the Swedish Medical Products Agency (MPA) presents an initiative aiming to introduce environmental constraints into the EU GMP Guidelines. The reason for this is based on the near inexistence of environmental concerns in the countries where the manufacture of APIs is outsourced. Read more here about this initiative.

more

27.07.11

Which kind of GMP Documentation is needed for an API Manufacturer who performs Sterilisation of an active Substance

The European Medicine Agency publishes answers to frequently asked questions after they are discussed and agreed to by the GMP/GDP Inspectors Working Group. In April 2011 the Agency published the following statement. Go here to read more.

more

20.07.11

WHO publishes Notice of Concern regarding GMP Deviations about two Manufactures located in India

The WHO Notice of Concern are very similar to FDA Warning Letters. These letters will be issued  to a manufacturer, contract research organization or quality control laboratory, by the WHO Prequalification of Medicines Programme. Read more about the two new Notice of Concerns here

more

13.07.11

Excipact - the Certification Scheme for Pharmaceutical Excipients

The Certification Scheme for pharmaceutical excipients elaborated by IPEC Americas, IPEC Europe and three further European partner associations contains standards for Good Manufacturing and Distributing Practices as well as requirements for 3rd party audit organisations and their auditors qualification. Learn more about the programme here.

more

13.07.11

The Falsified Medicines Directive published in the Official Journal of the European Union

On 1 July 2011 the Falsified Medicines Directive (2011/62EU) has been published in the Official Journal of the European Union. Now the countdown has started for the transposition of the Directive into national law by the EU Member States and for the adoption of Guidelines for APIs and pharmaceutical excipients by the EU Commission. Please read here more about the comprehensive legislation changes to come.

more

29.06.11

FDA announces New Worldwide Strategy on GMP Supervision and Importation

The manufacture of drugs, food, and medical devices is strongly fragmented and largely globalised. Because of this fact, there is an increase in the number of monitored manufacturing sites and imported products. This is a current issue in the USA. To meet new challenges, the FDA reacted with a strategy report. Read more here about the FDA planned change in strategy.

more

21.06.11

New ICH Q11 Guideline published

On June 16, 2011 the ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological entities) was published as a Step 3 document. Read more here.

more

01.06.11

The Council of the European Union adopts Falsified Medicines Directive! Major challenges for Users and Producers of APIs and pharmaceutical Excipients to be expected

The Falsified Medicines Directive has been adopted by the Council of the European Union on 27 May 2011. It is now about to be published in the Official Journal of the European Union within the next days. It contains substantial changes with respect to GMPs for APIs and pharmaceutical excipients. Please read here more about these new challenges for the API and pharmaceutical industry.

more

18.05.11

Suspension and Withdrawal of CEPs by EDQM

The EDQM announced on May 17, 2011 the availability of the revised policy document 'Suspension or Withdrawal of a Certificate of Suitability'. The EDQM also annouced information about new CEP suspensions and withdrawals due to failures to comply with the GMP requirements. Read more here.

more

11.05.11

Quality by Design for pharmaceutical Excipients - IPEC publishes new Checklists and Q&A Document

Three new documents published by the IPEC provide useful information for suppliers and users of APIs on Quality by Design at early stages of development.  Read more here.

more

04.05.11

New PIC/S Document on GMP for APIs

A new document created by a PIC/S team of APIs experts raises the central issue related to the production and distribution of APIs and provides essential answers and clarification on the topic. Read more about the interesting collection of Questions and Answers here. 

more

20.04.11

EDQM requires more Information on the Manufacturer's Localisation (DUNS/GPS) for CEPs

From 15 April, the European Directorate for the Quality of Medicines and Health Care (EDQM) requires for applications or revisions of a Certification of Suitability (CEP) the indication of the manufacturing site localisation with GPS data or a DUNS number. This change is in line with the requirements laid down in the new EU Site Master File. Read more here

more

30.03.11

Video Presentation from FDA´s Dr Moheb Nasr available

A presentation from Dr Moheb Nasr about FDA´s Pharmaceutical Quality Initiatives was videotaped at the 13th European API Conference in Barcelona. Click here to read more.

more

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics